Skip to content

Utilizing Helpline for Opioid Dependence Treatment

Utilizing Helpline for Opioid Dependence Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03969238
Enrollment
31
Registered
2019-05-31
Start date
2019-06-25
Completion date
2021-05-04
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Dependence

Keywords

opioid dependence, pain management

Brief summary

The investigator propose to develop an opioid telephone helpline, where trained counselors and educators provide referral, educational and targeted interventions and support to individuals interested in addressing their addiction or needing help with managing their pain. The proposed application builds on "tobacco quit line" efforts, a nationally-adopted telephone-based service, providing education materials, access to cessation medication and counseling against tobacco use. Similar to tobacco quit line; the proposed telephone based services will remove barriers to treatment as they help individuals at the exact time of need. The helpline will also educate individuals with new onset pain about pain expectations, relaxation techniques, use of pharmacology and psychotherapy for treatment in addition to providing support for coping and reducing dependency on prescription opioids. It will be a low cost, easily accessible and utilizable technology to augment the clinical outcome of medication assisted treatment of opioid use disorder and pain management.

Detailed description

The proposed specific aims are to: 1. Test if the helpline is a resourceful tool for patients with opioid use disorder looking for referrals and support to access treatment. The opioid helpline will provide individuals with opioid use disorder seeking treatment, direct access to a live person who can answer questions regarding referrals and various treatment programs. The helpline will also follow-up on treatment compliance and offer support and motivational techniques for these individuals to stay engaged in treatment 2. Test if the helpline is a resourceful tool for patients with new onset of pain or chronic pain being prescribed opioids. The opioid helpline will provide these individuals the necessary educational materials on managing pain safely while avoiding misuse. It will offer free imagery guided meditation and other non-pharmacological tools to help with pain management. 3. Test if providers find the opioid helpline helpful and resourceful for their practice and are willing to refer patients to the helpline.

Interventions

BEHAVIORALHelpline

This helpline will aim to provide patients with new diagnosis of pain who are prescribed opioids, access to education, support and free behavioral technique to help manage their pain such as mindfulness exercises. For those with opioid use disorder, the helpline will offer support in the form of education about the disorder, opioid withdrawal symptoms, risks of overdoses, and a variety of services such as help reach appropriate care with MAT licensed providers, information on FDA-approved MAT and naloxone, and, in some cases, behavioral intervention to keep patients engaged in treatment. The opioid helpline will provide a central resource for direct services and a portal for community services. It will also serve as a referral resource for health-care professionals.

Sponsors

University of Virginia
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participant Criteria: 1. Age greater than or equal to 18 years. 2. A formal diagnosis of Opioid Use Disorder (OUD) by a health care provider or 3. If no formal diagnosis of OUD, having a self-reported concern with opioid use or addiction. 4. An individual seeking to reduce opioid use. 5. An individual concerned about opioids prescribed for management of new-onset pain or chronic pain. Provider Criteria: 1. University of Virginia: Providers of any specialties within VA including dentists that prescribes opioids. 2. County of Wise: Providers of any specialties including dentists that prescribes opioids.

Exclusion criteria

Participant Criteria: 1. Individuals under 18 years of age. 2. Individuals seeking treatment for non-opioid substance use disorders 3. Individuals who have no pain issues 4. Individuals located outside of Virginia. Provider Criteria: Providers outside the designated regions.

Design outcomes

Primary

MeasureTime frameDescription
Participant Opioid Helpline Surveyup to a yearPrimary outcomes measure the rating of the Helpline by the patients. They will be sent surveys that will ask the patients to rate the services they receive on a scale of 1 to 10, with 1 meaning they are very dissatisfied and 10 meaning they are very satisfied.
Provider Opioid Helpline Surveyup to a yearPrimary outcomes measure the rating of the Helpline by the providers. They will be sent surveys that will ask the providers to rate the services they receive on a scale of 1 to 10, with 1 meaning they are very dissatisfied and 10 meaning they are very satisfied.

Secondary

MeasureTime frameDescription
Number of participants reached versus called.up to a yearTotal number of contacts to the Helpline compared to the number that prescreened and the number consented.
Number of participants who continued to access the services of Helplineup to a yearThe investigator will measure the number of participants who continued to access the services of Helpline up to a year.
New General Self-Efficacy Measureup to a yearBy using this survey, the investigator will determine the participant's ability to handle the situation that prompted the participant to call the Helpline originally.
Opioid Helpline Study Screen Formup to a yearThis will be use to collect demographic information for individuals who self-identify as needing help or resources from the Helpline.
Referral follow-upsup to a yearAssess which referrals were followed up on by the participants.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNassima Ait-Daoud Tiouririne, M.D.

University of Virginia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026